Left hemispheric predominance of nigrostriatal dysfunction in Parkinson's disease

被引:89
|
作者
Scherfler, Christoph [1 ]
Seppi, Klaus [1 ]
Mair, Katherina J. [1 ]
Donnemiller, Eveline [2 ]
Virgolini, Irene [2 ]
Wenning, Gregor K. [1 ]
Poewe, Werner [1 ]
机构
[1] Innsbruck Med Univ, Dept Neurol, A-6020 Innsbruck, Austria
[2] Innsbruck Med Univ, Dept Nucl Med, A-6020 Innsbruck, Austria
关键词
Parkinson's disease; laterality; dopamine transporter; SPECT; DOPAMINE TRANSPORTERS; HUMAN-BRAIN; IN-VIVO; SEROTONIN TRANSPORTERS; MOTOR ASYMMETRY; CIT SPECT; HANDEDNESS; BINDING; TOMOGRAPHY; REGISTRATION;
D O I
10.1093/brain/aws253
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The aim of this study was to investigate the distribution and the degree of asymmetric putaminal dopamine transporter availability in right-handed patients with Parkinson's disease and its association with the severity of lateralized motor signs. Asymmetry of motor symptoms was defined by the difference between right- and left-sided scores for lateralized items assessed by the Unified Parkinson's Disease Rating Scale Motor Score in a series of 68 patients with Parkinson's disease (disease duration 2.1 +/- 1.5 years; Unified Parkinson's Disease Rating Scale Motor Score 22.7 +/- 9). Putaminal dopamine transporter availability was measured with the radioligand [I-123]beta-carboxymethyoxy-3 -beta-(4-iodophenyl) tropane ([I-123]beta-CIT) and single photon emission computed tomography. We found that in the right-handed Parkinson's disease cohort, the number of patients who had lower dopamine transporter uptake in the left posterior putamen was significantly greater compared with those with lower uptake in the right posterior putamen (Parkinson's disease-left group, n = 49; Parkinson's disease-right group, n = 19; P < 0.001). In addition, one-way analysis of variance revealed significant reductions of mean total putaminal [I-123]beta-CIT binding of the Parkinson's disease-right patients compared with Parkinson's disease-left patients (P < 0.05).The preponderance of reduced left putaminal dopamine transporter availability strengthens clinical observations of a greater proportion of right-handed patients with Parkinson's disease with predominantly right-sided motor signs and argues against a randomly distributed asymmetric vulnerability of substantia nigra dopaminergic neurons. The coexistence of a subgroup of right-handed patients with Parkinson's disease with more severe and predominant ipsilateral putaminal dopamine transporter decline suggests that asymmetry of dopaminergic denervation and motor dysfunction in Parkinson's disease cannot be fully explained by hemispheric dominance alone, but that other factors must be involved.
引用
收藏
页码:3348 / 3354
页数:7
相关论文
共 50 条
  • [31] Diffusion Tensor Imaging of the Nigrostriatal Fibers in Parkinson's Disease
    Zhang, Yu
    Wu, I-Wei
    Buckley, Shannon
    Coffey, Christopher S.
    Foster, Eric
    Mendick, Susan
    Seibyl, John
    Schuff, Norbert
    MOVEMENT DISORDERS, 2015, 30 (09) : 1229 - 1236
  • [32] Decrease of nicotinic receptors in the nigrostriatal system in Parkinson's disease
    Kas, Aurelie
    Bottlaender, Michel
    Gallezot, Jean Dominique
    Vidailhet, Marie
    Villafane, Gabriel
    Gregoire, Marie Claude
    Coulon, Christine
    Valette, Heric
    Dolle, Frederic
    Ribeiro, Maria-Joao
    Hantraye, Philippe
    Remy, Philippe
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2009, 29 (09) : 1601 - 1608
  • [33] Onset pattern of nigrostriatal denervation in early Parkinson's disease
    Pineda-Pardo, Jose A.
    Sanchez-Ferro, Alvaro
    Monje, Mariana H. G.
    Pavese, Nicola
    Obeso, Jose A.
    BRAIN, 2022, 145 (03) : 1018 - 1028
  • [34] EXERCISE IN AN ANIMAL MODEL OF PARKINSON'S DISEASE: MOTOR RECOVERY BUT NOT RESTORATION OF THE NIGROSTRIATAL PATHWAY
    Churchill, M. J.
    Pflibsen, L.
    Sconce, M. D.
    Moore, C.
    Kim, K.
    Meshul, C. K.
    NEUROSCIENCE, 2017, 359 : 224 - 247
  • [35] Zonisamide reduces nigrostriatal dopaminergic neurodegeneration in a mouse genetic model of Parkinson's disease
    Sano, Hiromi
    Murata, Miho
    Nambu, Atsushi
    JOURNAL OF NEUROCHEMISTRY, 2015, 134 (02) : 371 - 381
  • [36] Brain perfusion correlates of cognitive and nigrostriatal functions in de novo Parkinson's disease
    Nobili, Flavio
    Arnaldi, Dario
    Campus, Claudio
    Ferrara, Michela
    De Carli, Fabrizio
    Brugnolo, Andrea
    Dessi, Barbara
    Girtler, Nicola
    Morbelli, Silvia
    Abruzzese, Giovanni
    Sambuceti, Gianmario
    Rodriguez, Guido
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (12) : 2209 - 2218
  • [37] High-accuracy Automated Diagnosis of Parkinson's Disease
    Ozsahin, Ilker
    Sekeroglu, Boran
    Pwavodi, Pwadubashiyi Coston
    Mok, Greta S. P.
    CURRENT MEDICAL IMAGING, 2020, 16 (06) : 688 - 694
  • [38] Parkinson's disease laterality: a11C-PE2I PET imaging study
    Roussakis, Andreas-Antonios
    Zeng, Zhou
    Lao-Kaim, Nicholas P.
    Martin-Bastida, Antonio
    Piccini, Paola
    JOURNAL OF NEUROLOGY, 2021, 268 (02) : 582 - 589
  • [39] Inhibitory Motor Dysfunction in Parkinson's Disease Subtypes
    Gong, Tao
    Xiang, Yuanyuan
    Saleh, Muhammad G.
    Gao, Fei
    Chen, Weibo
    Edden, Richard A. E.
    Wang, Guangbin
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2018, 47 (06) : 1610 - 1615
  • [40] The role of neuroimaging in Parkinson's disease
    Bidesi, Natasha S. R.
    Vang Andersen, Ida
    Windhorst, Albert D.
    Shalgunov, Vladimir
    Herth, Matthias M.
    JOURNAL OF NEUROCHEMISTRY, 2021, 159 (04) : 660 - 689